Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients

Mitochondrion

Volumn 10, Issue 2, 2010, Pages 94-101

  Norman, Kimberly G ^a,b   Canter, Jeffrey A ^b   Shi, Mingjian ^a   Milne, Ginger L ^c   Morrow, Jason D ^c   Sligh, James E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell death; Cyclosporine A; Organ transplantation; Oxidative stress; Skin cancer; UVA

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN A [4 N METHYLISOLEUCINE]; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KERATINOCYTE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RADIATION EXPOSURE; SKIN CANCER; ULTRAVIOLET A RADIATION;

CELL DEATH; CELL LINE; CELL SURVIVAL; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; ORGAN TRANSPLANTATION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 76049119424     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2009.10.001     Document Type: Article

References (47)

1. Agar N.S., Halliday G.M., Barnetson R.S., Ananthaswamy H.N., Wheeler M., and Jones A. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl. Acad. Sci. USA 101 (2004) 4954-4959
2. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., and Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
3. Basso E., Fante L., Fowlkes J., Petronelli V., Forte M.A., and Bernardi P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J. Biol. Chem. 280 (2005) 18558-18561
4. Belli R., Amerio P., Brunetti L., Orlando G., Toto P., Proietto G., Vacca M., and Tulli A. Elevated 8-isoprostane levels in basal cell carcinoma and in UVA irradiated skin. Int. J. Immunopathol. Pharmacol. 18 (2005) 497-502
5. Berg D., and Otley C.C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J. Am. Acad. Dermatol. 47 (2002) 1-17
6. Berneburg M., Grether-Beck S., Kurten V., Ruzicka T., Briviba K., Sies H., and Krutmann J. Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J. Biol. Chem. 274 (1999) 15345-15349
7. Boukamp P., Petrussevska R.T., Breitreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
8. Cooke M.S., Osborne J.E., Singh R., Mistry V., Farmer P.B., Evans M.D., and Hutchinson P.E. Evidence that oxidative stress is a risk factor for the development of squamous cell carcinoma in renal transplant patients. Free Radic. Biol. Med. 43 (2007) 1328-1334
9. Duncan F.J., Wulff B.C., Tober K.L., Ferketich A.K., Martin J., Thomas-Ahner J.M., Allen S.D., Kusewitt D.F., Oberyszyn T.M., and Vanbuskirk A.M. Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. Am. J. Transplant. 7 (2007) 2693-2703
10. Ekberg H., Grinyo J., Nashan B., Vanrenterghem Y., Vincenti F., Voulgari A., Truman M., Nasmyth-Miller C., and Rashford M. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am. J. Transplant. 7 (2007) 560-570
11. Euvrard S., Kanitakis J., and Claudy A. Skin cancers after organ transplantation. N. Engl. J. Med. 348 (2003) 1681-1691
12. Friberg H., and Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84 (2002) 241-250
13. Godar D.E. UVA1 radiation triggers two different final apoptotic pathways. J. Invest. Dermatol. 112 (1999) 3-12
14. Gonzalez Maglio D.H., Paz M.L., Ferrari A., Weill F.S., Czerniczyniec A., Leoni J., and Bustamante J. Skin damage and mitochondrial dysfunction after acute ultraviolet B irradiation: relationship with nitric oxide production. Photodermatol. Photoimmunol. Photomed. 21 (2005) 311-317
15. Guba M., von Breitenbuch P., Steinbauer M., Koehl G., Flegel S., Hornung M., Bruns C.J., Zuelke C., Farkas S., Anthuber M., Jauch K.W., and Geissler E.K. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat. Med. 8 (2002) 128-135
16. Halestrap A.P., Connern C.P., Griffiths E.J., and Kerr P.M. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol. Cell. Biochem. 174 (1997) 167-172
17. Hansson M.J., Mattiasson G., Mansson R., Karlsson J., Keep M.F., Waldmeier P., Ruegg U.T., Dumont J.M., Besseghir K., and Elmer E. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria. J. Bioenerg. Biomembr. 36 (2004) 407-413
18. Hartevelt M.M., Bavinck J.N., Kootte A.M., Vermeer B.J., and Vandenbroucke J.P. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49 (1990) 506-509
19. He Y.Y., Pi J., Huang J.L., Diwan B.A., Waalkes M.P., and Chignell C.F. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene 25 (2006) 3680-3688
20. Herman M., Weinstein T., Korzets A., Chagnac A., Ori Y., Zevin D., Malachi T., and Gafter U. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J. Lab. Clin. Med. 137 (2001) 14-20
21. Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., Shimbo T., and Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397 (1999) 530-534
22. Jensen P., Hansen S., Moller B., Leivestad T., Pfeffer P., Geiran O., Fauchald P., and Simonsen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J. Am. Acad. Dermatol. 40 (1999) 177-186
23. Kim J.S., He L., and Lemasters J.J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem. Biophys. Res. Commun. 304 (2003) 463-470
24. Kim J.S., He L., Qian T., and Lemasters J.J. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr. Mol. Med. 3 (2003) 527-535
25. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., and Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366 (1998) 177-196
26. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52 (2001) 159-164
27. Lindelof B., Sigurgeirsson B., Gabel H., and Stern R.S. Incidence of skin cancer in 5356 patients following organ transplantation. Br. J. Dermatol. 143 (2000) 513-519
28. Marcil I., and Stern R.S. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet 358 (2001) 1042-1045
29. Matsumura Y., and Ananthaswamy H.N. Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 195 (2004) 298-308
30. Matsuura K., Kabuto H., Makino H., and Ogawa N. Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice. Neurosci. Lett. 230 (1997) 191-194
31. Milne G.L., Sanchez S.C., Musiek E.S., and Morrow J.D. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc. 2 (2007) 221-226
32. Morley N., Rapp A., Dittmar H., Salter L., Gould D., Greulich K.O., and Curnow A. UVA-induced apoptosis studied by the new apo/necro-Comet-assay which distinguishes viable, apoptotic and necrotic cells. Mutagenesis 21 (2006) 105-114
33. Nakagawa T., Shimizu S., Wananabe T., Yamaguchi O., Otsu K., Yamagata H., Inohara H., Kubo T., and Tsujimoto Y. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434 (2005) 652-658
34. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin. Transpl. 147 (1998) 158
35. Petronilli V., Miotto G., Canton M., Brini M., Colonna R., Bernardi P., and Di Lisa F. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76 (1999) 725-734
36. Randle H.W. The historical link between solid-organ transplantation, immunosuppression, and skin cancer. Dermatol. Surg. 30 (2004) 595-597
37. Sander C.S., Chang H., Salzmann S., Muller C.S., Ekanayake-Mudiyanselage S., Elsner P., and Thiele J.J. Photoaging is associated with protein oxidation in human skin in vivo. J. Invest. Dermatol. 118 (2002) 618-625
38. Sander C.S., Chang H., Hamm F., Elsner P., and Thiele J.J. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int. J. Dermatol. 43 (2004) 326-335
39. Stepkowski S.M. Molecular targets for existing and novel immunosuppressive drugs. Expert Rev. Mol. Med. 2000 (2000) 1-23
40. Tanaka T., Takahara S., Hatori M., Suzuki K., Wang J., Ichimaru N., Suzaki S., Morozumi K., Okuyama A., and Yamanaka H. A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine. Cancer Lett. 181 (2002) 165-171
41. Tang X., Zhu Y., Han L., Kim A.L., Kopelovich L., Bickers D.R., and Athar M. CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice. J. Clin. Invest. 117 (2007) 3753-3764
42. Vincenti F., Monaco A., Grinyo J., Kinkhabwala M., and Roza A. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am. J. Transplant. 3 (2003) 306-311
43. Waldmeier P.C., Feldtrauer J.J., Qian T., and Lemasters J.J. Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. Mol. Pharmacol. 62 (2002) 22-29
44. Walsh C.T., Zydowsky L.D., and McKeon F.D. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. J. Biol. Chem. 267 (1992) 13115-13118
45. Wong A., and Cortopassi G. MtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. Biochem. Biophys. Res. Commun. 239 (1997) 139-145
46. Yarosh D.B., Pena A.V., Nay S.L., Canning M.T., and Brown D.A. Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J. Invest. Dermatol. 125 (2005) 1020-1025
47. Zamzami N., Larochette N., and Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ. 12 (2005) 1478-1480